Pharmacokinetic and pharmacodynamic assessment of alirocumab in patients with familial hypercholesterolemia associated with proprotein convertase subtilisin/kexin type 9 gain-of-function or apolipoprotein B loss-of-function mutations
| Autor: | Hopkins, Paul N., Krempf, Michel, Bruckert, Eric, Donahue, Stephen, Yang, Feng, Zhang, Yi, DiCioccio, A. Thomas |
|---|---|
| Zdroj: | In Journal of Clinical Lipidology November-December 2019 13(6):970-978 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect